162
Participants
Start Date
January 31, 2008
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Naproxen Sodium 440 mg (BAYH6689) / DPH 50mg
Participants received 2 tablets of Naproxen Sodium 220 mg and 2 tablets of Diphenhydramine hydrochloride (DPH) 25 mg, single dose, orally.
Naproxen Sodium 440 mg (BAYH6689)
Participants received 2 tablets of Naproxen Sodium 220mg and 2 tablets of placebo, single dose, orally.
Naproxen Sodium 220 mg (BAYH6689) / DPH 50mg
One dose of naproxen sodium 220 mg plus diphenhydramine 50 mg
Naproxen Sodium 220 mg (BAYH6689)
Participants received 1 tablet of Naproxen Sodium 220 mg and 3 tablets of placebo, single dose, orally.
DPH 50mg
Participants received 2 tablets of Diphenhydramine hydrochloride (DPH) 25 mg and 2 tablets of placebo, single dose, orally.
Ibuprofen 400 mg / Diphenhydramine citrate 76 mg
Participants received 2 tablets of Advil PM (ibuprofen 200 mg and diphenhydramine citrate 38 mg) and 2 tablets of Placebo, single dose, orally.
Salt Lake City
Lead Sponsor
Bayer
INDUSTRY